Login / Signup

Heart size disparity drives sex-specific response to cardiac resynchronization therapy: a post-hoc analysis of the MORE-MPP CRT trial.

Nadeev WijesuriyaVishal Shahil MehtaFelicity De VereSandra HowellSteven A NiedererHaran BurriJohannes SperzelLeonardo CalòBernard ThibaultWenjiao LinKwangdeok LeeAndrea GrammaticoNiraj VarmaMarianne GwechenbergerChristophe LeclercqChristopher A Rinaldi
Published in: medRxiv : the preprint server for health sciences (2023)
In the NICM LBBB population, increased relative dyssynchrony in females, who have smaller heart sizes than their male counterparts, is a driver of sex-specific CRT response, particularly at QRSd <150ms. Females may benefit from CRT at a QRSd <130ms, opening the debate on whether sex-specific QRSd cut-offs or QRS/LVEDV measurement should be incorporated into clinical guidelines.
Keyphrases
  • cardiac resynchronization therapy
  • heart failure
  • left ventricular
  • mass spectrometry
  • multiple sclerosis
  • ms ms
  • atrial fibrillation
  • clinical trial
  • study protocol
  • phase ii
  • open label